Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Jun 10, 2024

Akums Launches Gastrointestinal Tract Disorders Post DCGI Nod

Akums Launches Gastrointestinal Tract Disorders Post DCGI Nod
Drug pills. (Source: Unsplash)
STOCKS IN THIS STORY
Nifty MidSmall India Consumption
--
Norris Medicines Ltd.
--

Akums Drugs & Pharmaceuticals on Monday said it has launched a combination drug for gastrointestinal tract disorders.

The contract development and manufacturing organisation has launched Rabeprazole and Levosulpiride SR capsules after getting approval from the Drug Controller General of India, it said in a statement.

Akums Drugs & Pharmaceuticals Joint Managing Director Sandeep Jain said the medication offers an effective remedy by easing symptoms, enhancing gastrointestinal function, and boosting patients' overall well-being.

"Clinical studies have demonstrated that Rabeprazole not only alleviates heartburn but also improves other dyspepsia-related symptoms. Levosulpiride offers rapid relief and better healing outcomes with fewer side effects, elevating the overall treatment experience," he added.

GERD, or gastro-oesophageal reflux disease is characterised by the reflux of stomach contents into the oesophagus, leading to troublesome symptoms and potential complications.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search